The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies
Open accessAbstract
BACKGROUND: Endometriosis is a risk factor for epithelial ovarian cancer; however, whether this risk extends to all invasive histological subtypes or borderline tumours is not clear. We undertook an international collaborative study to assess the association between endometriosis and histological subtypes of ovarian cancer. METHODS: Data from 13 ovarian cancer case-control studies, which were part of the Ovarian Cancer Association Consortium, were pooled and logistic regression analyses were undertaken to assess the association between self-reported endometriosis and risk of ovarian cancer. Analyses of invasive cases were done with respect to histological subtypes, grade, and stage, and analyses of borderline tumours by histological subtype. Age, ethnic origin, study site, parity, and duration of oral contraceptive use were included in all analytical models. FINDINGS: 13 226 controls and 7911 women with invasive ovarian cancer were included in this analysis. 818 and 738, respectively, reported a history of endometriosis. 1907 women with borderline ovarian cancer were also included in the analysis, and 168 of these reported a history of endometriosis. Self-reported endometriosis was associated with a significantly increased risk of clear-cell (136 [20·2%] of 674 cases vs 818 [6·2%] of 13 226 controls, odds ratio 3·05, 95% CI 2·43-3·84, p<0·0001), low-grade serous (31 [9·2%] of 336 cases, 2·11, 1·39-3·20, p<0·0001), and endometrioid invasive ovarian cancers (169 [13·9%] of 1220 cases, 2·04, 1·67-2·48, p<0·0001). No association was noted between endometriosis and risk of mucinous (31 [6·0%] of 516 cases, 1·02, 0·69-1·50, p=0·93) or high-grade serous invasive ovarian cancer (261 [7·1%] of 3659 cases, 1·13, 0·97-1·32, p=0·13), or borderline tumours of either subtype (serous 103 [9·0%] of 1140 cases, 1·20, 0·95-1·52, p=0·12, and mucinous 65 [8·5%] of 767 cases, 1·12, 0·84-1·48, p=0·45). INTERPRETATION: Clinicians should be aware of the increased risk of specific subtypes of ovarian cancer in women with endometriosis. Future efforts should focus on understanding the mechanisms that might lead to malignant transformation of endometriosis so as to help identify subsets of women at increased risk of ovarian cancer. FUNDING: Ovarian Cancer Research Fund, National Institutes of Health, California Cancer Research Program, California Department of Health Services, Lon V Smith Foundation, European Community's Seventh Framework Programme, German Federal Ministry of Education and Research of Germany, Programme of Clinical Biomedical Research, German Cancer Research Centre, Eve Appeal, Oak Foundation, UK National Institute of Health Research, National Health and Medical Research Council of Australia, US Army Medical Research and Materiel Command, Cancer Council Tasmania, Cancer Foundation of Western Australia, Mermaid 1, Danish Cancer Society, and Roswell Park Alliance Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“endometrioid cancer (OR 2.21)”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al. (2012)
In the citing paper
“It is becoming clear that epigenetics and genomic instability associated with the particular microenvironment of endometriosis characterized by oxidative stress, inflammatory process and high estrogen levels contribute to the process of malignant transformation of endometriosis (Pearce et al., 2012, Nezhat et al., 2014).”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al., 2012
In the citing paper
“and low-grade serous invasive ovarian cancers (OR 2.21).”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al. (2012)
In the citing paper
“Pearce et al. (2012), concluded that self-reported endometriosis was associated with significantly increased risk for CCC [odds ratio (OR) 3.05]”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al. (2012)
In the citing paper
“Pearce et al. summarized 13 case-control studies and reported the highest odds ratio of 3.05 for clear cell carcinoma, followed by LG-serous (2.11) and endometrioid carcinoma (2.04) in patients with endometriosis [9].”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [9]
In the citing paper
“Malignant transformation of ovarian endometriosis has been well documented.”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [9]
In the citing paper
“In population-based studies, the incidence of ovarian cancer in patients with a history of ovarian endometriosis is 1.35-1.49times greater compared with those without this history [9,10].”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [9]
In the citing paper
“Of these, we observed associations with multiple diseases or traits, including epithelial ovarian cancer21, low-density lipoprotein cholesterol22, coronary heart disease23, luteinizing hormone and follicle-stimulating hormone levels, and age at onset for menopause24.”
From Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism (2017) · cites this paper as [21]
In the citing paper
“Most recently, in a study of 13 226 controls and 7911 women with invasive ovarian cancer, self-reported endometriosis was associated with a significantly increased risk of clear-cell, low-grade serous, and endometrioid invasive ovarian cancers.”
From Defining Future Directions for Endometriosis Research: Workshop Report From the 2011 World Congress of Endometriosis in Montpellier, France (2013) · cites this paper as [118]
In the citing paper
“No association was noted between endometriosis and risk of mucinous or high-grade serous invasive ovarian cancer or borderline tumors of either subtype.118”
From Defining Future Directions for Endometriosis Research: Workshop Report From the 2011 World Congress of Endometriosis in Montpellier, France (2013) · cites this paper as [118]
In the citing paper
“Endometriosis and ovarian cancer have been linked by a number of studies.”
From Defining Future Directions for Endometriosis Research: Workshop Report From the 2011 World Congress of Endometriosis in Montpellier, France (2013) · cites this paper as [118]
In the citing paper
“which have been (suggested to be) associated with endometriosis or its constituting symptoms in epidemiologic studies (51–54).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Kurman, R. J., & Shih, I. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181cf3d79 · Cited by 1,890
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Wiegand, K. C., Shah, S. P., Al-Agha, O. M., Zhao, Y., Tse, K., Zeng, T., Senz, J., McConechy, M. K., Anglesio, M. S., Kalloger, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008433 · Cited by 1,712
Self-citationEskenazi, B., & Warner, M. L. (1997) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70302-8 · Cited by 1,617
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
Kurman, R. J., & Shih, I. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.03.003 · Cited by 1,099
Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events
Bradburn, M. J., Deeks, J. J., Berlin, J. A., & Russell Localio, A. (2007) · Statistics in Medicine · doi:10.1002/sim.2528 · Cited by 938
Ovarian Tumors in a Cohort of Infertile Women
Rossing, M. A., Daling, J. R., Weiss, N. S., Moore, D. E., & Self, S. G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311204 · Cited by 721
Self-citationCancer risk after a hospital discharge diagnosis of endometriosis
Brinton, L. A., Gridley, G., Persson, I. R., Baron, J. A., & Bergqvist, A. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70550-7 · Cited by 549
Infertility, Fertility Drugs, and Ovarian Cancer: A Pooled Analysis of Case-Control Studies
Ness, R. B. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.3.217 · Cited by 425
Self-citationRisk of cancer after use of fertility drugs with in-vitro fertilisation
Venn, A., Watson, L., Bruinsma, F., Giles, G. G., & Healy, D. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05203-4 · Cited by 368
Endometriosis and the risk of cancer with special emphasis on ovarian cancer
Melin, A., Sparén, P., Persson, I., & Bergqvist, A. (2006) · Human Reproduction · doi:10.1093/humrep/dei462 · Cited by 306
Cited by
Sorted by citations
Items 501–600 of 946
Genomic insights in gynecologic cancer
Roddy, E., & Chapman, J. (2016) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2016.11.001 · Cited by 12
Gaia‐Oltean, A. I., Pop, L., Cojocneanu, R., Buse, M., Zimța, A., Kubelac, P. M., Irimie, A., Coza, O. F., Roman, H., & Berindan‐Neagoe, I. (2021) · PubMed Central · Cited by 12
Association between Ovarian Endometriomas and Stage of Endometriosis
Seraji, S., Ali, A., Demirel, E., Akerman, M. B., NEZHAT, C. R., & Nezhat, F. R. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13154530 · Cited by 12
Blanc‐Durand, F., Ngoi, N. Y. L., Lim, D. G. S., & Tan, D. S. P. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-1205 · Cited by 11
Ovarian cancer extracellular vesicle biomarkers
Jamali, Z., Razipour, M., Zargar, M., Ghasemnejad‐Berenji, H., & Akrami, S. M. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.120011 · Cited by 11
Clearer Horizons: The latest advances in clear cell ovarian cancer treatment
Blanc‐Durand, F., Ngoi, N. Y. L., Lim, D. G. S., Ray-Coquard, I. L., & Tan, D. S. P. (2025) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2025.102977 · Cited by 11
Manning‐Geist, B. L., Gordhandas, S., Hodgson, A., Zhou, Q. C., Iasonos, A. E., Dennis, S., Ellenson, L. H., Aghajanian, C. A., Abu‐Rustum, N. R., Leitão, M. M., et al. (2022) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2022-003935 · Cited by 11
Endometriosis and epithelial ovarian cancer: a two-sample Mendelian randomization analysis
Wang, L., Li, X., Wang, Y., Li, G., Dai, S.-Z., Cao, M., Meng, Z. H., & Ren, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-49276-x · Cited by 11
Renner, S. P., Strissel, P. L., Beckmann, M. W., Lermann, J. H., Burghaus, S., Hackl, J., Fasching, P. A., & Strick, R. (2015) · BioMed Research International · doi:10.1155/2015/450468 · Cited by 11
Self-citationCramer, D. W., Williams, K. A., Vitonis, A. F., Yamamoto, H. S., Stuebe, A. M., Welch, W. R., Titus, L. J., & Fichorova, R. N. (2013) · Cancer Causes & Control · doi:10.1007/s10552-013-0266-1 · Cited by 11
Self-citationEndometriosis: The gynecologist's opinion
Marana, R., Lecca, A., Biscione, A., & Muzii, L. (2012) · Urologia Journal · doi:10.5301/ru.2012.9391 · Cited by 11
Carcinosarcoma arising from uterine adenomyosis: A case report
Kiuchi, K., Hasegawa, K., Kanamori, A., Machida, H., Kojima, M., & Fukasawa, I. (2015) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.12901 · Cited by 11
Clear cell ovarian cancer and endometriosis: is there a relationship?
Szubert, M., Suzin, J., Obirek, K., Sochacka, A., & Łoszakiewicz, M. (2016) · Menopause Review/Przegląd Menopauzalny · doi:10.5114/pm.2016.61190 · Cited by 11
Kondo, E., Maki, S., Nii, M., Yoshida, K., Tabata, T., & Ikeda, T. (2018) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13773 · Cited by 11
Zhou, A., Minlikeeva, A. N., Khan, S., & Moysich, K. B. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-1214 · Cited by 11
Self-citationThe role of imaging as a guide to the surgical treatment of endometriosis
Burnett, T. L., Feldman, M., & Huang, J. Q. (2020) · Abdominal Radiology · doi:10.1007/s00261-019-02399-0 · Cited by 11
Genetic Contribution of Endometriosis to the Risk of Developing Hormone-Related Cancers
Rueda-Martínez, A., Garitazelaia, A., Cilleros‐Portet, A., Marí, S., Arauzo, R., de Miguel, J., González‐García, B. P., Fernández‐Jiménez, N., Bilbao, J. R., & García‐Santisteban, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116083 · Cited by 11
Maragliano, R., Libera, L., Carnevali, I. W., Pensotti, V., Vecchi, G. D., Testa, M., Amaglio, C., Leoni, E., Formenti, G., Sessa, F., et al. (2021) · Endocrine Pathology · doi:10.1007/s12022-021-09689-8 · Cited by 11
Lee, A. W., Bomkamp, A., Bandera, E. V., Jensen, A., Ramus, S. J., Goodman, M. T., Rossing, M. A., Modugno, F., Moysich, K. B., Chang-Claude, J. C., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30274 · Cited by 11
Self-citationRisk Factors for Ovarian Cancers With and Without Microsatellite Instability
Segev, Y., Pal, T., Rosen, B. P., McLaughlin, J. R., Sellers, T. A., Risch, H. A., Zhang, S., Sun, P., Narod, S. A., & Schildkraut, J. M. (2014) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000134 · Cited by 11
Self-citationRetractedHernández, A., Sanz, A., Spagnolo, E., Carbonell, M., González, E. R., López, A. C. A., Raganato, R., Forno, S. D., & Ramiro‐Cortijo, D. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092414 · Cited by 10
Immune pathway through endometriosis to ovarian cancer
Calmon, M. S., Lemos, F. F. B., Luz, M. S., Pinheiro, S. L. R., Silva, L. G. D. O., Santos, G. L. C., Rocha, G. R., & de Melo, F. F. (2024) · World Journal of Clinical Oncology · doi:10.5306/wjco.v15.i4.496 · Cited by 10
Endometrioid ovarian carcinoma landscape: pathological and molecular characterization
de Nonneville, A. T., Kalbacher, E., Cannone, F. G., Guillé, A., Adélaı̈de, J., Finetti, P., Cappiello, M., Lambaudie, É., Ettore, G., Charafe‐Jauffret, E., et al. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13679 · Cited by 10
Fumagalli, D., Jayraj, A. S., Olearo, E., Capasso, I., Hsu, H., Tzur, Y., Piedimonte, S., Jugeli, B., Santana, B. N., Vitis, L. A. D., et al. (2025) · International Journal of Gynecological Cancer · doi:10.1016/j.ijgc.2025.101664 · Cited by 10
Ochoa, S., Rasquel-Oliveira, F. S., McKinnon, B. D., Haro, M., Subramaniam, S., Yu, P. H., Coetzee, S. G., Anglesio, M. S., Wright, K. N., Meyer, R., et al. (2025) · Advanced Science · doi:10.1002/advs.202415285 · Cited by 11
Eurich, K. E., Goff, B. A., & Urban, R. R. (2019) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2018.12.011 · Cited by 10
The relation between endometrioma and ovarian cancer
Sorbi, F., Capezzuoli, T., Saso, S., Fambrini, M., CORDA, M., Fantappiè, G., & Petraglia, F. (2021) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.21.04757-2 · Cited by 10
Barbosa, A., Pinto, P., Peixoto, A., Guerra, J., Pinheiro, M., Santos, C., Pinto, C., Escudeiro, C., Bartosch, C., Santos, R. P., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.754094 · Cited by 10
Xu, T., Zhang, L., Jiang, Y., Wan, Y., Zhou, S., Sun, G., Cheng, W., & Yuan, L. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14695 · Cited by 10
Kelemen, L. E., Köbel, M., Chan, A., Taghaddos, S., & Dinu, I. A. (2013) · BioMed Research International · doi:10.1155/2013/815894 · Cited by 10
The Role of Minimally Invasive Surgery in Ovarian Cancer
Nezhat, F. R., & Lavie, O. (2013) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e31828f3ae3 · Cited by 10
Gallardo‐Rincón, D., Espinosa-Romero, R., Muñoz, W. R., Mendoza-Martínez, R., del Villar-Álvarez, S., Oñate-Ocaña, L. F., Isla‐Ortiz, D., Márquez-Manríquez, J. P., Apodaca-Cruz, Á., & Meneses-García, A. (2016) · Salud Pública de México · doi:10.21149/spm.v58i2.7801 · Cited by 10
Liu, G., Mukherjee, B., Lee, S., Lee, A. W., Wu, A. H., Bandera, E. V., Jensen, A., Rossing, M. A., Moysich, K. B., Chang‐Claude, J., et al. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx243 · Cited by 10
Self-citationEpidemiologic Relationship Between Obesity and Ovarian Cancer
Jochem, C., Schlecht, I., & Leitzmann, M. F. (2017) · Energy balance and cancer · doi:10.1007/978-3-319-63483-8_2 · Cited by 10
Contralateral ovarian endometrioma recurrence after unilateral salpingo-oophorectomy
Hidari, T., Hirata, T., Arakawa, T., Koga, K., Neriishi, K., Fukuda, S., Nakazawa, A., Nagashima, N., Ma, S., Sun, H., et al. (2019) · BMC Women s Health · doi:10.1186/s12905-019-0760-z · Cited by 10
Sánchez‐Borrego, R., & Prieto, M. S. (2020) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2020.1849617 · Cited by 10
Capmas, P., Suarthana, E., & Tulandi, T. (2021) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2021.02.022 · Cited by 10
Role of repressed microRNAs in endometriosis
Nasu, K., Aoyagi, Y., Zhu, R., Okamoto, M., Yano, M., Kai, K., & Kawano, Y. (2021) · Medical Molecular Morphology · doi:10.1007/s00795-021-00303-8 · Cited by 10
Link between endometriosis and ovarian-cancer subtypes
Gourley, C. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70029-3 · Cited by 10
Babić, A., Harris, H. R., Vitonis, A. F., Titus, L. J., Jordan, S. J., Webb, P. M., Australian Ovarian Cancer Study Group, Risch, H. A., Rossing, M. A., Doherty, J. A., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.31010 · Cited by 10
Self-citationExpression of MTA1 in endometriosis and its relationship to the recurrence
Zhang, J., Wang, H., Meng, Q., Chen, J., Wang, J., & Huang, S. (2018) · Medicine · doi:10.1097/md.0000000000012115 · Cited by 10
Nagasawa, S., Ikeda, K., Horie‐Inoue, K., Sato, S., Takeda, S., Hasegawa, K., & Inoue, S. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej19-0283 · Cited by 10
Sohel, H. I., Kiyono, T., Zahan, U. F., Razia, S., Ishikawa, M., Yamashita, H., Kanno, K., Sonia, S. B., Nakayama, K., & Kyo, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051995 · Cited by 9
de Santiago, P. R., Sato, S., Zhang, S. J., Dougher, M. C., Devins, K. M., Bilecz, A. J., Rayamajhi, S., Mingo, G., Rendulich, H. S., Feng, Y., et al. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00849-1 · Cited by 9
Lee, H. J., Lee, B., Choi, H., Lee, M., Lee, K., Lee, T. K., Hwang, S. O., & Kim, Y. B. (2024) · Cancers · doi:10.3390/cancers16040809 · Cited by 9
A new classification of ovarian tumors
Франк, Г. А., Moskvina, L. V., & Andreeva, Y. Y. (2015) · Russian Journal of Archive of Pathology · doi:10.17116/patol201577440-50 · Cited by 9
Ishibashi, H., Takano, M., Miyamoto, M., Soyama, H., Matsuura, H., Aoyama, T., Yoshikawa, T., Kato, K., Tsuda, H., & Furuya, K. (2017) · Molecular and Clinical Oncology · doi:10.3892/mco.2017.1468 · Cited by 9
Factors associated with ovarian endometriosis malignancy and its recurrence in Chinese women
Zhang, Y., & Qu, P. (2019) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2019.1603209 · Cited by 9
Cai, Y., Yin, J., Jin, Y., Li, Y., Wu, M. P., Yang, J., Huang, H., Leng, J., & Pan, L. (2019) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2019.11.517 · Cited by 9
Vatansever, D., Taşkıran, Ç., Meydanlı, M. M., Güngördük, K., Akbayır, Ö., Yalçın, İ., Demirkıran, F., Sözen, H., Özgül, N., Çelik, H., et al. (2021) · Journal of Surgical Oncology · doi:10.1002/jso.26450 · Cited by 9
Src as a novel therapeutic target for endometriosis
Lawrenson, K., Lee, N., Torres, H. A. M., Lee, J. M., Brueggmann, D., Rao, P. N., Noushmehr, H., & Gayther, S. A. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.06.016 · Cited by 9
Self-citationHysterectomy and risk of ovarian cancer: a systematic review and meta-analysis
Huo, X., Yao, L., Han, X., Li, W., Liu, J., Zhou, L., Gou, Y., Yang, K., & Liu, H. (2019) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-5020-1 · Cited by 9
Gremke, N., Griewing, S., Göhring, J., Isselhard, A., Wagner, U. A. G., Kostev, K., & Kalder, M. (2023) · Breast Cancer Research and Treatment · doi:10.1007/s10549-023-07211-8 · Cited by 8
Endometriosis and endometrial cancer: A propensity score-adjusted real-world data study
Farolfi, A., Gentili, N., Testoni, S., Rusconi, F., Massa, I., Danesi, V., Altavilla, A., Cursano, M. C., Gurioli, G., Burgio, S. L., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109680 · Cited by 8
A Narrative Review Regarding Implication of Ovarian Endometriomas in Infertility
Văduva, C.-C., Dȋră, L. M., Boldeanu, L., Şerbănescu, M.-S., & Carp-Velişcu, A. (2025) · Life · doi:10.3390/life15020161 · Cited by 8
Controversies in the management of clear cell carcinoma of the uterus and ovary
Sachdeva, M., Blanc‐Durand, F., & Tan, D. S. P. (2025) · International Journal of Gynecological Cancer · doi:10.1016/j.ijgc.2025.101681 · Cited by 8
Huang, J., Yang, S., Wu, P., Wang, C., Tang, C., & Wang, P.-H. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18168754 · Cited by 8
High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival
Brieger, K. K., Phung, M. T., Mukherjee, B., Bakulski, K. M., Anton-Culver, H., Bandera, E. V., Bowtell, D. D. L., Cramer, D. W., DeFazio, A., Doherty, J. A., et al. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0977 · Cited by 8
Self-citationInfertilitetsbehandling og kreftrisiko
Storeng, R., Vangen, S., Omland, A. K., & Oldereid, N. B. (2012) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.12.0376 · Cited by 8
Distinguishing the progression of an endometrioma: Benign or malignant?
Baştu, E., Önder, S. Y., Demiral, İ., Özsürmeli, M., Keskin, G., Takmaz, Ö., Özaltın, S., Görgen, H., Güngör, M., Yavuz, E., et al. (2018) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2018.09.026 · Cited by 8
Carcinoma of the Ovaries and Fallopian Tubes
Coleman, R. L., Liu, J., Matsuo, K., Thaker, P. H., Westin, S. N., & Sood, A. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00086-4 · Cited by 8
Ouldamer, L., Body, G., Daraï, É., & Bendifallah, S. (2020) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2020.01.012 · Cited by 8
Samimi, G., Sathyamoorthy, N., Tingen, C. M., Mazloomdoost, D., Conroy, J., Heckman‐Stoddard, B. M., & Halvorson, L. M. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.08.049 · Cited by 8
de Nonneville, A. T., Zemmour, C., Frank, S., Joly, F., Ray-Coquard, I. L., Costaz, H., Classe, J., Floquet, A., Rouge, T. D. L. M., Colombo, P., et al. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2021.07.019 · Cited by 8
Yang, S., Chang, W.-H., Lee, N.-R., Lai, W.-A., Shen, S.-H., Lee, W.-L., & Wang, P. (2021) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2021.09.027 · Cited by 8
Li, R., Wang, X., Zhang, Y., Xu, X., Wang, L., Wei, C., Liu, L., Wang, Z., & Li, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.852718 · Cited by 9
Orlando, M. S., Cadish, L. A., Shepherd, J. P., Falcone, T., Chang, O. H., & Kho, R. M. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.04.043 · Cited by 8
Canis, M. J., & Guo, S. (2023) · Human Reproduction · doi:10.1093/humrep/dead061 · Cited by 8
Gersekowski, K., Ibiebele, T. I., for the Australian Ovarian Cancer Study Group, Doherty, J. A., Harris, H. R., Goodman, M. T., Terry, K. L., Wu, A. H., Bandera, E. V., Qin, B., et al. (2023) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-23-0121 · Cited by 8
Self-citationYang, B., Wang, D., Chen, H., & Yang, F. (2015) · Nigerian Journal of Clinical Practice · doi:10.4103/1119-3077.158941 · Cited by 8
Itamochi, H., Oumi, N., Oishi, T., Taniguchi, F., Shoji, T., Fujiwara, H., Sugiyama, T., Suzuki, M., Kigawa, J., & Harada, T. (2015) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000414 · Cited by 8
Low-Stage High-Grade Serous Ovarian Carcinomas
Morency, E. G., Leitão, M. M., & Soslow, R. A. (2015) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0000000000000256 · Cited by 8
The Clinical and Experimental Research on the Treatment of Endometriosis with Thiostrepton
Jin, P., Chen, X., Yu, G., Li, Z., Zhang, Q., & Zhang, J. V. (2018) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520618666180108100211 · Cited by 8
Epidemiology of Ovarian and Endometrial Cancers
Terry, K. L., & Missmer, S. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-35153-7_13 · Cited by 8
Self-citationEndometriosis and ovarian cancer
Guo, S., Zilberberg, M. D., & Hummelshøj, L. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70199-7 · Cited by 8
A cellular and molecular portrait of endometriosis subtypesPreprint
Fonseca, M. A., Wright, K. N., Lin, X., Abbasi, F., Haro, M., Sun, J. K., Hernández, L., Orr, N. L., Hong, J., Choi-Kuaea, Y., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.20.445037 · Cited by 8
Self-citationMalignancies Associated with Extraovarian Endometriosis: A Literature Review
Inoue, N., Hirakawa, T., Mitsushita, J., Kitahara, Y., & Iwase, A. (2021) · Endocrines · doi:10.3390/endocrines2030024 · Cited by 7
“04) in patients with endometriosis [9].”
BackgroundAssociations between common contraceptive use and circulating inflammatory biomarkers
Mongiovi, J. M., Babic, A., Sasamoto, N., Shafrir, A. L., Huang, T., Townsend, M. K., Peres, L. C., Tworoger, S. S., & Terry, K. L. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae135 · Cited by 7
Self-citationVoigt, P. C., Chaudhari, A., Tsai, S., Milad, M. P., & Yang, L. C. (2025) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000001043 · Cited by 7
Comorbidity analysis and clustering of endometriosis patients using electronic health records
Khan, U., Oskotsky, T., Yilmaz, B. D., Roger, J. M., Gjoni, K., Irwin, J. C., Opoku‐Anane, J., Elhadad, N., Giudice, L. C., & Sirota, M. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102245 · Cited by 7
The immunotherapy era in ovarian clear cell carcinoma: current evidence and future perspective
Passarelli, A. M., Cecere, S. C., Ventriglia, J., Pisano, C., Cecio, R. D., Rossetti, S., Tambaro, R., Napoli, M. D., Lobianco, L., Calvanese, G., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1661048 · Cited by 7
The 34th Annual Meeting of the Korean Society of Gynecologic Oncology 2019: meeting report
Yim, G. W., Suh, D. H., Kim, J., Kim, S. C., & Kim, Y. T. (2019) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2019.30.e91 · Cited by 7
Malignant risk of pelvic mass after hysterectomy for adenomyosis or endometriosis
Chao, X., Liu, Y., Ji, M., Wang, S., Shi, H., Fan, Q., & Lang, J. (2020) · Medicine · doi:10.1097/md.0000000000019712 · Cited by 7
Xie, Z., Ding, X., Wang, Y., & Zhang, M. (2023) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2023.2199852 · Cited by 7
Clinical perspectives of rare ovarian tumors: clear cell ovarian cancer
Fujiwara, S. (2023) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyad057 · Cited by 7
Brønd, M., Breintoft, K., Forman, A., Henriksen, T. B., Ramlau‐Hansen, C. H., Rytter, D., & Arendt, L. H. (2023) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14594 · Cited by 7
Genomic instability in ovarian cancer: Through the lens of single nucleotide polymorphisms
Sistla, H. C., Talluri, S., Rajagopal, T., Venkatabalasubramanian, S., & Dunna, N. R. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119992 · Cited by 7
New developments in reproductive surgery
Gordts, S. (2013) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2012.11.004 · Cited by 7
The Difference of Bax Protein Expression between Endometrioma and Ovarian Carcinoma
Saragih, C. F., Rivany, R., Sahil, M. F., Fadjrir, F., Ardiansyah, E., Yaznil, M. R., & Sarirah, M. (2019) · Molecular and Cellular Biomedical Sciences · doi:10.21705/mcbs.v3i2.50 · Cited by 7
Huebner, H., Lubrich, H., Blum, S., Antoniadis, S., Lermann, J. H., Ekici, A. B., Fasching, P. A., Beckmann, M. W., Ruebner, M., & Burghaus, S. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.08.004 · Cited by 7
Self-citationA clearer view on ovarian clear cell carcinoma
Pauw, A. D., Naert, E., de Vijver, K. K. V., Tummers, P., Vandecasteele, K., & Denys, H. G. (2021) · Acta Clinica Belgica · doi:10.1080/17843286.2021.1964051 · Cited by 7
Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma
Handley, K. F., Mehta, S., Martin, A. L., Biswas, S., Maharaj, K. K., Nagy, M. Z., Mine, J. A., Cortina, C., Yu, X., Sprenger, K. B., et al. (2023) · Gynecologic Oncology · doi:10.1016/j.ygyno.2023.03.020 · Cited by 7
Penciu, R. C., Postolache, I., Steriu, L., Izvoranu, S., Tica, A.-A., Mocanu, I.-D., Sârbu, V., Deacu, M., Tica, I., Bălţătescu, G. I., et al. (2020) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.61.1.18 · Cited by 7
Peres, L. C., Bethea, T. N., Camacho, T. F., Bandera, E. V., Beeghly-Fadiel, A. C., Chyn, D., Harris, H. R., Joslin, C. E., Moorman, P. G., Myers, E. R., et al. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa188 · Cited by 7
Self-citationJust, P., Moret, S., Borghese, B., & Chapron, C. (2021) · Annales de Pathologie · doi:10.1016/j.annpat.2021.03.012 · Cited by 7
Plasma metabolites associated with endometriosis in adolescents and young adults
Lin, N., Zeleznik, O. A., Vitonis, A. F., Laliberte, A., Shafrir, A. L., Ávila-Pacheco, J., Clish, C. B., Terry, K. L., Missmer, S. A., & Sasamoto, N. (2025) · Human Reproduction · doi:10.1093/humrep/deaf040 · Cited by 6
Self-citationZhang, M., Zhang, Y., Zhang, Y., Zhang, W., Zhang, X., Ding, J., Sun, N., & Deng, C. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c05483 · Cited by 6
Emerging trends and treatment strategies in ovarian cancer: A comprehensive review
Krishna, B. M., Garg, P., Ramisetty, S. K., Nair, M., Kulkarni, P., Horne, D. A., Wang, W., Salgia, R., & Singhal, S. S. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105177 · Cited by 6
Dual influence of TNFα on diverse in vitro models of ovarian cancer subtypes
Kocbek, V., Imboden, S., Nirgianakis, K., Mueller, M. D., & McKinnon, B. D. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06099 · Cited by 6
Liposomal DQ in Combination with Copper Inhibits ARID1A Mutant Ovarian Cancer Growth
Kang, X., Wang, Q., Wu, S., Wang, C., Annaji, M., Huang, C.-H., Shen, J., Chen, P., & Babu, R. J. (2023) · Biomolecules · doi:10.3390/biom13050744 · Cited by 6
Metadata
- Authors
- Pearce, C. L., Templeman, C., Rossing, M. A., Lee, A., Near, A. M., Webb, P. M., Nagle, C. M., Doherty, J. A., Cushing-Haugen, K. L., Wicklund, K. G., Chang-Claude, J., Hein, R., Lurie, G., Wilkens, L. R., Carney, M. E., Goodman, M. T., Moysich, K., Kjaer, S. K., Hogdall, E., Jensen, A., Goode, E. L., Fridley, B. L., Larson, M. C., Schildkraut, J. M., Palmieri, R. T., Cramer, D. W., Terry, K. L., Vitonis, A. F., Titus, L. J., Ziogas, A., Brewster, W., Anton-Culver, H., Gentry-Maharaj, A., Ramus, S. J., Anderson, A. R., Brueggmann, D., Fasching, P. A., Gayther, S. A., Huntsman, D. G., Menon, U., Ness, R. B., Pike, M. C., Risch, H., Wu, A. H., & Berchuck, A.
- Affiliations
- University of Southern California (US)
- Fred Hutch Cancer Center (US)
- Georgetown University Medical Center (US)
- QIMR Berghofer Medical Research Institute (AU)
- German Cancer Research Center (DE)
- University of Hawaiʻi at Mānoa (US)
- Roswell Park Comprehensive Cancer Center (US)
- Danish Cancer Society (DK)
- Mayo Clinic (US)
- Duke Medical Center (US)
- Brigham and Women's Hospital (US)
- Dartmouth College (US)
- University of California, Irvine (US)
- University of North Carolina at Chapel Hill (US)
- University College London (GB)
- University of California, Los Angeles (US)
- Yale University (US)
- Corresponding author
- Pearce, Celeste Leigh
- ORCID
- Pearce, Celeste Leigh
- Lee, Alice
- Near, Aimee M
- Webb, Penelope M
- Nagle, Christina M
- Doherty, Jennifer A
- Wicklund, Kristine G
- Wilkens, Lynne R
- Goodman, Marc T
- Moysich, Kirsten
- Jensen, Allan
- Goode, Ellen L
- Fridley, Brooke L
- Larson, Melissa C
- Schildkraut, Joellen M
- Cramer, Daniel W
- Terry, Kathryn L
- Titus, Linda J
- Ziogas, Argyrios
- Brewster, Wendy
- Ramus, Susan J
- Fasching, Peter A
- Gayther, Simon A
- Menon, Usha
- Pike, Malcolm C
- Risch, Harvey
- Wu, Anna H
- Berchuck, Andrew
- Venue
- The Lancet Oncology
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 13
- Issue
- 4
- Pages
- 385-394
- ISSN
- 1470-2045 (ISSN-L)
- PMC
- PMC3664011
- OpenAlex
- W2125681453
- Cited by
- 939
- References
- 43
- Citations by year
- 2026: 47 · 2025: 53 · 2024: 46 · 2023: 64 · 2022: 44 · 2021: 84 · 2020: 88 · 2019: 77 · 2018: 71 · 2017: 83 · 2016: 68 · 2015: 65 · 2014: 55 · 2013: 68 · 2012: 26
- FWCI
- 79.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Lancet Oncology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- California Breast Cancer Research Program (0001389V20170, 2110200)
- Seventh Framework Programme (HEALTH-F2-2009-223175)
- University of South China
- National Institutes of Health (5R01 CA074850, CA14089, CA17054, CA58860, CA61132, CA92044, N01 CN67001, N01 PC35137, N01 PC67010, P50 CA105009, P50 CA136393, PSA 042205, R01 CA112523, R01 CA122443, R01 CA126841, R01 CA136891, R01 CA54419, R01 CA58598, R01 CA61107, R01 CA76016, R01 CA87538, R01 CA95023, R03 CA113148)
- Medical Research and Materiel Command (DAMD 170110729, DAMD17-02-1-0669, W81XWH0610220, W81XWH1010280)
- Oak Foundation
- Lon V. Smith Foundation (LVS 39420)
- California Department of Public Health (050E8709)
- Roswell Park Alliance Foundation, Roswell Park Cancer Institute
- Kræftens Bekæmpelse
- Deutsches Krebsforschungszentrum
- National Health and Medical Research Council (199600)
- Cancer Council Tasmania
- American University of Sharjah
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Keywords
- endometriosis, ovarian cancer, histological subtypes, ovarian clear cell carcinoma, low-grade serous ovarian cancer, endometrioid ovarian cancer, mucinous ovarian carcinoma, high-grade serous ovarian cancer, borderline ovarian tumors, cancer risk factors, oral contraceptive use, parity, tumor stage and grade, Ovarian Cancer Association Consortium
- MeSH terms
- Aged, Aged, 80 and over, Endometriosis, Ethnicity, Female, Humans, Middle Aged, Neoplasm Invasiveness, Neoplasm Staging, Ovarian Neoplasms, Risk Factors, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
